```json
{
"content": [
{
"type": "paragraph",
"content": "The Bovine Fetuin ecosystem follows a linear value chain from upstream raw‑material sourcing, through mid‑stream purification and formulation, to downstream distribution for end‑user applications. Upstream actors obtain bovine plasma or purified fetuin fractions from livestock farms and reagent suppliers. Mid‑stream participants convert these inputs into research‑grade or clinical‑grade product using chromatography, lyophilization, and quality‑control processes. Downstream channels—specialty distributors, contract manufacturers, and scientific service firms—deliver the final material to laboratories, diagnostic developers, and pharmaceutical pipelines. Value is primarily captured during purification and formulation, where purity, stability, and regulatory compliance differentiate offerings."
},
{
"type": "list",
"items": [
{ "text": "Raw material/component suppliers — provide bovine plasma or purified fetuin fractions sourced from livestock farms.", "level": 1 },
{ "text": "Technology providers — supply chromatography, filtration, and analytical platforms enabling high‑purity fetuin production.", "level": 1 },
{ "text": "OEM manufacturers — conduct bulk purification, lyophilization, and packaging of fetuin for commercial sale.", "level": 1 },
{ "text": "System integrators/EPCs — design and operate integrated production lines that meet GMP and cGMP standards.", "level": 1 },
{ "text": "Distributors/channel partners — manage inventory, logistics, and regulatory documentation for regional market access.", "level": 1 },
{ "text": "Service providers/after‑sales — offer technical support, custom assay development, and stability testing for customers.", "level": 1 },
{ "text": "End users/buyers — academic researchers, diagnostic manufacturers,
